These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7359239)

  • 1. Acquired inhibitors of coagulation in nonhemophiliac children.
    Brodeur GM; O'Neill PJ; Willimas JA
    J Pediatr; 1980 Mar; 96(3 Pt 1):439-41. PubMed ID: 7359239
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined factor VIII and IX inhibitors in a girl.
    Reussi C; Altman R; Rouvier J; Maino R
    Thromb Diath Haemorrh; 1966 Dec; 16(3):549-58. PubMed ID: 5996674
    [No Abstract]   [Full Text] [Related]  

  • 3. Acquired coagulation-factor deficiencies.
    Hocking DR
    Med J Aust; 1970 Mar; 1(13):657-9. PubMed ID: 5427311
    [No Abstract]   [Full Text] [Related]  

  • 4. Activated prothrombin concentrate for patients with factor VIII inhibitors.
    Kurczynski EM; Penner JA
    N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485
    [No Abstract]   [Full Text] [Related]  

  • 5. Concurrent acquired inhibitors to factor VIII and IX, a laboratory artifact: a case report.
    Doma SA; Hillarp A; Pajič T; Andoljšek D; Černelč P; Preldžnik Zupan I
    Biochem Med (Zagreb); 2016; 26(2):279-84. PubMed ID: 27346976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enhanced activity of diminished blood clotting factors in inborn blood coagulation defects].
    Mingers AM; Mietens C; Ströder J
    Thromb Diath Haemorrh; 1971 Jun; 25(2):316-31. PubMed ID: 5568051
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of the weak factor VIII inhibitors].
    Mayer G; Noel G; Waitz R
    Acta Haematol; 1969; 42(1):27-41. PubMed ID: 4982619
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined factor VIII and IX inhibitors in a non-haemophilic patient: successful treatment with immunosuppressive drugs.
    Carmassi F; Giannarelli C; De Giorgi A; De Negri F
    Haemophilia; 2007 Jan; 13(1):106-7. PubMed ID: 17212735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood coagulation disorders caused by abnormal blood coagulation factors].
    Fiedler H
    Z Arztl Fortbild (Jena); 1972 Jul; 66(13):692-8. PubMed ID: 4636972
    [No Abstract]   [Full Text] [Related]  

  • 10. Naturally occurring anticoagulants: a case report.
    Ross SA
    N Z Med J; 1968 Mar; 67(430):411-3. PubMed ID: 4968117
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemophilia. Variants of factor 8 and IX].
    Meyer D; Dray L; Larrieu MJ
    Nouv Rev Fr Hematol; 1970; 10(5):619-26. PubMed ID: 4250285
    [No Abstract]   [Full Text] [Related]  

  • 12. A macroglobulin with inhibitory activity against coagulation factor VIII.
    Castaldi PA; Penny R
    Blood; 1970 Mar; 35(3):370-6. PubMed ID: 4985542
    [No Abstract]   [Full Text] [Related]  

  • 13. Modification of the Bethesda assay for factor VIII or IX inhibitors to improve efficiency.
    Gadarowski JJ; Czapek EE; Ontiveros JD; Pedraza JL
    Acta Haematol; 1988; 80(3):134-8. PubMed ID: 3143212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of factors VIII and IX in a child with Henoch-Schönlein syndrome.
    Gouyon JB; Seiller F; Deries X; Alison M; Lorenzini JL; Devilliers E
    Am J Pediatr Hematol Oncol; 1985; 7(4):376-7. PubMed ID: 3936372
    [No Abstract]   [Full Text] [Related]  

  • 15. Acquired factor-IX inhibitor in a nonhaemophilic patient with autoimmune disease.
    Largo R; Sigg P; von Felten A; Straub PW
    Br J Haematol; 1974 Jan; 26(1):129-40. PubMed ID: 4211775
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunologically generated circulating anticoagulants in humans.
    Edwards RL; Wakem CJ
    Surv Immunol Res; 1984; 3(1):64-9. PubMed ID: 6426006
    [No Abstract]   [Full Text] [Related]  

  • 17. Acquired inhibitors of blood coagulation.
    Feinstein DI; Rapaport SI
    Prog Hemost Thromb; 1972; 1():75-95. PubMed ID: 4569725
    [No Abstract]   [Full Text] [Related]  

  • 18. Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacs.
    Kraiem I; Hadhri S; El Omri H; Sassi R; Chaabani W; Ennabli S; Skouri H
    Ann Biol Clin (Paris); 2012; 70(6):659-65. PubMed ID: 23207810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired factor VIII inhibitor associated with lung abscess.
    Ganly PS; Isaacs JD; Laffan MA; Haslett C; Hows JM
    Br Med J (Clin Res Ed); 1987 Oct; 295(6602):811. PubMed ID: 3119053
    [No Abstract]   [Full Text] [Related]  

  • 20. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.